R&D
The future of Oxford: Science, technology, and collaboration
In conversation with Professor Lady Sue Black and Simon Ruck about Oxford North, from opening to today.
Sales & Marketing
Changing Faces: Agency, consultancy, and investor hires, Apr...
The agency, consultancy, and investor segments saw a wave of senior-level appointments across April and May.
R&D
Why are eCOA studies still so challenging?
Although eCOA has been in clinical trials for decades, we continue to hit the same road blocks during operational set-up and implementation.
Digital
Sponsored
12 Questions with Sam Dixey
Find out more about Sam Dixey, Head of Medical Affairs Innovation and Technology (MAIT) at LUCENT Biopharma.
Market Access
A dynamic moment for pharma pricing: Insights from PPIC
At PPIC in Basel, pharma pricing experts discussed how policy changes and AI advances are altering the dynamics of pharmaceutical pricing and access.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
